BioQ Pharma Status
The company received $91.40 million of development capital from Madryn Asset Management, Visionary Private Equity Group and other undisclosed investors on November 2, 2018. Madryn Asset Management also provided $55 million of debt financing as part of the deal. The company intends to use the proceeds from the investment to expand existing commercial operations, support anticipated near-term regulatory approvals, and advance earlier-stage development activities. Hercules capital also participated.